Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neuroblastoma 11Brain Neoplasms 3Recurrence 2Osteosarcoma 2Multiple Myeloma 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Glioma 2Glioblastoma 2Diffuse Intrinsic Pontine Glioma 2Xanthomatosis, Cerebrotendinous 1Vaccinia 1Uveal Melanoma 1Transplant-Related Hematologic Malignancy 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Resectable Esophageal Cancer 1Prostatic Neoplasms 1Pathologic Complete Response 1Oligodendroglioma 1Neoplasms 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Influenza, Human 1

Interventions

Vincristine 13Temozolomide 12Cyclophosphamide 11Irinotecan 8Magnetic Resonance Spectroscopy 7X-Rays 6Vinorelbine 6Specimen Handling 6Phantoms, Imaging 6Dactinomycin 6Biopsy 5fludarabine 4Radiotherapy 4Radiation 4Nuclear Medicine Department, Hospital 4Filgrastim 4Etoposide 4pegfilgrastim 3irinotecan sucrosofate 3Sirolimus 3Proton Therapy 3Melphalan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × Granulocyte-Macrophage Colony-Stimulating Factor × 1 year × Clear all
NCT04238819 2026-03-02

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Eli Lilly and Company

Phase 1/2 Completed
47 enrolled 36 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡